When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Espondiloartrite axial

Última revisão: 22 Jul 2025
Última atualização: 02 Apr 2024

Resumo

Definição

História e exame físico

Principais fatores diagnósticos

  • presença de fatores de risco
  • dorsalgia inflamatória
  • irite/uveíte
  • entesite
  • apresentação no final da adolescência e logo após os 20 anos
  • sexo masculino
  • história familiar positiva de espondilite anquilosante (EA)
Detalhes completos

Outros fatores diagnósticos

  • fadiga
  • perturbação do sono
  • sensibilidade na articulação sacroilíaca
  • dispneia
  • perda de lordose lombar
  • comprometimento das articulações periféricas
  • cifose
  • psoríase
  • sintomas de doença inflamatória intestinal
Detalhes completos

Fatores de risco

  • HLA (antígeno leucocitário) B27
  • polimorfismos nos genes aminopeptidase 1 do retículo endoplasmático (ERAP1) e receptor de interleucina 23 (IL23R)
  • história familiar positiva de espondilite anquilosante (EA)
  • sexo masculino
Detalhes completos

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • radiografia pélvica
Detalhes completos

Investigações a serem consideradas

  • HLA (antígeno leucocitário) B27
  • RNM
  • radiografia da coluna cervical (lateral)
  • radiografia da coluna lombar (lateral)
  • radiografia da coluna torácica (lateral)
  • ultrassonografia
Detalhes completos

Algoritmo de tratamento

AGUDA

adultos com dor e/ou rigidez

adultos sem dor e/ou rigidez

crianças

CONTÍNUA

adultos com dor e/ou rigidez refratária a 2 anti-inflamatórios não esteroidais (AINEs) e medidas não farmacológicas

Colaboradores

Autores

Antoni Chan, MBChB, FRCP, PhD

Consultant

Rheumatology Department

Royal Berkshire NHS Foundation Trust

Reading

UK

Disclosures

AC has served on the advisory boards for MSD, Novartis, and Sanofi; contributed to educational events for Janssen, MSD, Novartis, Sanofi, and Celgene; been on the speaker bureau for Janssen, Pfizer, and Novartis; and received travel grants from AbbVie, UCB, Lilly, and Pfizer to attend educational conferences.

Sarah Sacks, MBBS, BSc

Specialist Registrar in Rheumatology

Stoke Mandeville Hospital

Aylesbury

UK

Disclosures

SS declares that she has no competing interests.

Acknowledgements

Dr Antoni Chan and Dr Sarah Sacks would like to gratefully acknowledge Dr Jessica Gunn, Dr Sarah Keidel, Dr Millicent Stone, Dr Raj Sengupta, Dr Athimalaipet V. Ramanan, and Dr Emma Pomeroy, the previous contributors to this topic. We would like to gratefully acknowledge the late Dr Andrew Keat, Consultant Physician and Rheumatologist at Northwick Park Hospital for his contribution to this topic as a peer reviewer.

Disclosures

JG, SK, RS, and AVR declare that they have no competing interests. MS is an author of several references cited in this topic. EP is an author of a reference cited in this topic.

Peer reviewers

Roger Sturrock, MD, FRCP

Professor of Rheumatology

Centre for Rheumatic Diseases

University Department of Medicine

Glasgow Royal Infirmary University Trust

Glasgow

UK

Disclosures

RS is an author of a reference cited in this topic.

Karl Gaffney, BCh, BAO (Hons), FRCPI, FRCP

Consultant

Norfolk and Norwich University Hospital

Norwich and the Cromer & District Hospital

Cromer

UK

Disclosures

KG is an author of a reference cited in this topic.

Alexios G. Carayannopoulos, DO, MPH

Interventional Spine Physiatrist

Pain Medicine Specialist

Medical Director

Spine Center

Lahey Clinic

Burlington

MA

Disclosures

AGC declares that he has no competing interests.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Ramiro S, Nikiphorou E, Sepriano A, et al. ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis. 2023 Jan;82(1):19-34.Full text  Abstract

Ward MM, Deodhar A, Gensler LS, et al. 2019 update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network recommendations for the treatment of ankylosing spondylitis andnonradiographic axial spondyloarthritis. Arthritis Rheumatol. 2019 Oct;71(10):1599-613.Full text  Abstract

National Institute for Health and Care Excellence. Spondyloarthritis in over 16s: diagnosis and management. Jun 2017 [internet publication].Full text

Reference articles

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • Espondiloartrite axial images
  • Differentials

    • Osteoartrite
    • Hiperostose esquelética idiopática difusa (DISH)
    • Artrite psoriática
    More Differentials
  • Guidelines

    • Consensus on targeted drug therapy for spondyloarthritis
    • Guideline for vaccinations in patients with rheumatic and musculoskeletal diseases
    More Guidelines
  • Patient information

    Espondiloartrite axial: quais são as opções de tratamento?

    Espondiloartrite axial: o que é?

    More Patient information
  • Videos

    Demonstração animada de aspiração e injeção no joelho

    Demonstração animada de aspiração e injeção do ombro

    More videos
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer